Aileron Therapeutics, Inc. (ALRN): Price and Financial Metrics
ALRN Price/Volume Stats
Current price | $2.11 | 52-week high | $7.42 |
Prev. close | $1.93 | 52-week low | $1.61 |
Day low | $1.96 | Volume | 63,300 |
Day high | $2.17 | Avg. volume | 64,833 |
50-day MA | $2.70 | Dividend yield | N/A |
200-day MA | $3.28 | Market Cap | 45.72M |
ALRN Stock Price Chart Interactive Chart >
Aileron Therapeutics, Inc. (ALRN) Company Bio
Aileron Therapeutics is a clinical-stage biopharmaceutical company advancing a novel class of therapeutics called stapled peptides, which represent the first general solution, or "scaffold" for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. The company's lead product candidate ALRN-6924 is being evaluated in multiple clinical trials. The company was founded in 2005 and is based in Cambridge, Massachusetts.
ALRN Price Returns
1-mo | 0.00% |
3-mo | -44.91% |
6-mo | 14.05% |
1-year | -56.04% |
3-year | -75.29% |
5-year | -84.80% |
YTD | -8.26% |
2024 | -24.56% |
2023 | 28.63% |
2022 | -78.95% |
2021 | -45.88% |
2020 | 81.50% |
Loading social stream, please wait...